Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA by Rosanna Asselta, Valeria Rimoldi, Ilaria Guella, Giulia Soldà, Raimondo De Cristofaro, Flora Peyvandi, and Stefano Duga Blood Volume 115(10):2065-2072 March 11, 2010 ©2010 by American Society of Hematology Global screening of the F11 splicing pattern. Rosanna Asselta et al. Blood 2010;115:2065-2072 ©2010 by American Society of Hematology Characterization of F11 alternatively spliced transcripts. Rosanna Asselta et al. Blood 2010;115:2065-2072 ©2010 by American Society of Hematology Impact of pharmacologic inhibition of the NMD pathway on F11 splicing and quantification of the alternative transcript lacking exons 6+7. Rosanna Asselta et al. Blood 2010;115:2065-2072 ©2010 by American Society of Hematology Metabolic labeling of wild-type and Δ6/7 mutant recombinant FXI in transiently transfected COS1 cells. Rosanna Asselta et al. Blood 2010;115:2065-2072 ©2010 by American Society of Hematology Quantitation by ELISA and measurement of the specific activity of wild-type and Δ6/7 recombinant FXIs. pcDNA3/FXI, or pcDNA3/FXI-Δ6/7, or equimolar amounts of both plasmids (heterozygous condition) were transiently transfected in COS-1 cells. Rosanna Asselta et al. Blood 2010;115:2065-2072 ©2010 by American Society of Hematology Immunoprecipitation of FXI Δ6/7 isoform from normal plasma. Rosanna Asselta et al. Blood 2010;115:2065-2072 ©2010 by American Society of Hematology